IES20140280A2 - Human targets II - Google Patents
Human targets IIInfo
- Publication number
- IES20140280A2 IES20140280A2 IES20140280A IES20140280A IES20140280A2 IE S20140280 A2 IES20140280 A2 IE S20140280A2 IE S20140280 A IES20140280 A IE S20140280A IE S20140280 A IES20140280 A IE S20140280A IE S20140280 A2 IES20140280 A2 IE S20140280A2
- Authority
- IE
- Ireland
- Prior art keywords
- human targets
- toi
- targets
- human
- interest
- Prior art date
Links
Abstract
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
Applications Claiming Priority (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361916862P | 2013-12-17 | 2013-12-17 | |
US201361916866P | 2013-12-17 | 2013-12-17 | |
GB1322253.4A GB2521356B (en) | 2013-12-17 | 2013-12-17 | Antibodies for use in treating conditions related to specific PCKS9 variants and associated diagnostic methods |
GB1322250.0A GB2521355A (en) | 2013-12-17 | 2013-12-17 | Human targets I |
US14/138,446 US8883157B1 (en) | 2013-12-17 | 2013-12-23 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/228,760 US8951523B1 (en) | 2013-12-17 | 2014-03-28 | Targeting rare human PCSK9 variants for cholesterol treatment |
EP14172579.6A EP2886558A1 (en) | 2013-12-17 | 2014-06-16 | Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations |
EP14172578.8A EP2886557A1 (en) | 2013-12-17 | 2014-06-16 | Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations |
US14/331,730 US9914769B2 (en) | 2014-07-15 | 2014-07-15 | Precision medicine for cholesterol treatment |
US14/331,609 US9051378B1 (en) | 2014-07-15 | 2014-07-15 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/331,665 US9023359B1 (en) | 2014-07-15 | 2014-07-15 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/457,536 US9017678B1 (en) | 2014-07-15 | 2014-08-12 | Method of treating rheumatoid arthritis using antibody to IL6R |
US14/457,566 US8945560B1 (en) | 2014-07-15 | 2014-08-12 | Method of treating rheumatoid arthritis using antibody to IL6R |
US14/472,698 US8986694B1 (en) | 2014-07-15 | 2014-08-29 | Targeting human nav1.7 variants for treatment of pain |
US14/472,828 US8986691B1 (en) | 2014-07-15 | 2014-08-29 | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US14/472,818 US8980273B1 (en) | 2014-07-15 | 2014-08-29 | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US14/472,685 US8992927B1 (en) | 2014-07-15 | 2014-08-29 | Targeting human NAV1.7 variants for treatment of pain |
US14/490,112 US9034331B1 (en) | 2014-07-15 | 2014-09-18 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/490,175 US9040052B1 (en) | 2013-12-17 | 2014-09-18 | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US14/490,091 US9068012B1 (en) | 2014-07-15 | 2014-09-18 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/490,160 US8999341B1 (en) | 2014-07-15 | 2014-09-18 | Targeting rare human PCSK9 variants for cholesterol treatment |
EP14185297.0A EP2975058A1 (en) | 2014-07-15 | 2014-09-18 | Antibodies for use in treating conditions related to specific PCSK9 variants in specific patient populations |
US14/500,397 US10618971B2 (en) | 2013-12-17 | 2014-09-29 | Targeting rare human PCSK9 variants for cholesterol treatment |
US14/500,233 US9045548B1 (en) | 2014-07-15 | 2014-09-29 | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US14/507,368 US9034332B1 (en) | 2014-07-15 | 2014-10-06 | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
IES20140280A2 true IES20140280A2 (en) | 2015-06-17 |
IES86602B2 IES86602B2 (en) | 2015-11-18 |
Family
ID=53398263
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IES20140279A IES86601B2 (en) | 2013-12-17 | 2014-11-07 | An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level |
IES20140280A IES86602B2 (en) | 2013-12-17 | 2014-11-07 | An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IES20140279A IES86601B2 (en) | 2013-12-17 | 2014-11-07 | An injectable antibody preparation for use in reducing or maintaining previously reduced cholesterol level |
Country Status (1)
Country | Link |
---|---|
IE (2) | IES86601B2 (en) |
-
2014
- 2014-11-07 IE IES20140279A patent/IES86601B2/en unknown
- 2014-11-07 IE IES20140280A patent/IES86602B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
IES86601B2 (en) | 2015-11-18 |
IES86602B2 (en) | 2015-11-18 |
IES20140279A2 (en) | 2015-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501763A1 (en) | Multispecific antibodies | |
EP3397261A4 (en) | Methods and compositions relating to chondrisomes | |
MX2017006217A (en) | Modulatory polynucleotides. | |
MX2018003491A (en) | Htt repressors and uses thereof. | |
AU2015287674B2 (en) | Topical antiviral compositions and methods of using the same | |
MX2016003843A (en) | Irak inhibitors and uses thereof. | |
MX2015008999A (en) | Mk2 inhibitors and uses thereof. | |
PH12017501077A1 (en) | Compositions and methods for antibodies targeting bmp6 | |
WO2015092393A3 (en) | Ligands specifically binding to human targets of interest | |
EP3102670A4 (en) | Systems, methods, and compositions relating to combiomics | |
MX2016016881A (en) | Antibodies binding axl. | |
WO2015066452A3 (en) | Methods of treating pediatric cancers | |
IN2015DN00127A (en) | ||
EP3258966A4 (en) | Methods, compositions, and kits for treatment of cancer | |
MX2020001756A (en) | Benzoquinolone inhibitors of vmat2. | |
SG10201902326XA (en) | Mk2 inhibitors and uses thereof | |
PH12015501059A1 (en) | Anti-hemagglutinin antibodies and methods of use | |
CY1120759T1 (en) | PREPARATION OF DIGLYCOSITE (S, S) -SECOCOSOLARICIRESINOL AND DIGLYCOSITE (R, R) -SECOSOSOLARICIRESINOL | |
MX2016009590A (en) | Apilimod compositions and methods for using same. | |
PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
EP3200582A4 (en) | Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers | |
MX2018000715A (en) | Methods for treating cancer using apilimod. | |
IN2013MU03641A (en) | ||
MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
CL2016000351A1 (en) | Method for quantification of actinium-227 in radio-223 compositions. |